According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the ...

Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...

Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check ...

Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024.

The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 13.93x ...

Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.

The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit ...

The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs ...

The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.